Bighorn sheep pneumonia: sorting out the cause of a polymicrobial disease

Thomas E Besser1, E Frances Cassirer, Margaret A Highland

  • 1Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA, USA. tbesser@vetmed.wsu.edu

Insights

Mycoplasma ovipneumoniae is the most likely cause of bighorn sheep pneumonia, a devastating disease. Preventing exposure to this pathogen is key to controlling outbreaks in wild sheep populations.

Area of Science:

  • Veterinary Medicine
  • Wildlife Disease Ecology
  • Infectious Disease Epidemiology

Background:

  • Bighorn sheep pneumonia is a severe disease with high mortality, first identified over 80 years ago.
  • The exact cause of this respiratory disease complex has been debated, with various pathogens including lungworms, Pasteurellaceae, and Mycoplasma ovipneumoniae proposed.
  • Previous research has struggled to definitively confirm causation for any single agent.

Purpose of the Study:

  • To review and evaluate the evidence for candidate primary causative agents of bighorn sheep pneumonia.
  • To determine the most parsimonious explanation for the disease based on established causal criteria.
  • To propose a model for disease transmission and inform control strategies.

Main Methods:

  • Systematic review of evidence for candidate pathogens (lungworms, Pasteurellaceae, Mycoplasma ovipneumoniae).
  • Evaluation of evidence based on criteria for causation: strength of association, temporality, plausibility, experimental evidence, and analogy.
  • Analysis of epidemiologic and microbiologic data to support or refute proposed etiologies.

Main Results:

  • While all proposed agents have some biological plausibility and Mannheimia haemolytica shows strong experimental evidence, Mycoplasma ovipneumoniae is the best supported by all causal criteria.
  • Experimental evidence suggests disease transmission from domestic sheep, consistent with Mycoplasma ovipneumoniae as the primary agent.
  • Healthy bighorn sheep appear immunologically naive to Mycoplasma ovipneumoniae.

Conclusions:

  • Mycoplasma ovipneumoniae is the most parsimonious explanation for bighorn sheep pneumonia.
  • Introduction of Mycoplasma ovipneumoniae into susceptible populations leads to epizootic polymicrobial bacterial pneumonia.
  • Segregation of bighorn sheep from Mycoplasma ovipneumoniae reservoirs is crucial for disease prevention; vaccine development for Mycoplasma ovipneumoniae may offer future control.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: